Digital Understanding the prevention and treatment needs for cardiov... What does the current picture of cardiovascular disease in Europe look like?
Digital The rise, acceleration and acceptance of telehealth adoption ‘Healing at a distance’ is the literal meaning of telemedicine.
Digital Targeted agents and immunotherapies Targeted agents and immunotherapies are two of the most promising areas for significant advancements in cancer treatment.
Digital An open call for innovation There is a bright future ahead for open innovation in pharma, as Almirall executive vice-president, research and development chief scientific officer Karl Ziegelbauer explains.
Digital Deep Dive: Digital Health 2021 There is no doubt that the COVID-19 pandemic has accelerated the adopt of digital health.
Patients How the combination treatment challenge impacts patients and... How the combination treatment challenge impacts patients
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.